The ability to adapt to stresses and privations is crucial for the survival and thus the longevity of any species. Sophisticated mechanisms are in place to perceive such dire conditions and relay them into the appropriate responses, that is, cytoprotective and homeostatic measures and sometimes even a reversible cessation of development or reproduction 1 . A core pathway for these responses in animals is the environmentally responsive insulin-like signalling pathway with its conserved downstream component, the forkhead transcription factor DAF-16/ FOXO (ref. 2). In the presence of ample food and optimal conditions, high insulin-like signalling inactivates DAF-16/FOXO through AKT kinase-mediated phosphorylation, causing cytoplasmic sequestration of DAF-16/FOXO by 14-3-3 proteins. Conversely, under dire conditions, cues that reduce insulin-like signalling and thus allow for reversal of DAF-16/FOXO phosphorylation enable DAF-16/FOXO to translocate to the nucleus, where it engages in transcriptional regulation. Several hundred DAF-16/FOXO target genes have been identified, and it is their concerted action that confers a wide range of beneficial effects on the organism-most notably stress resistance and longevity, but also metabolic responses, stem cell maintenance and tumour suppression 3, 4 . Although many studies have explored the signalling pathways leading to DAF-16/FOXO activation, little is known about the mechanisms or cofactors by which DAF-16/FOXO regulates its target genes.
and Supplementary Table S6 ) Fig. 1b ). Epitope-tagged DAF-16/FOXO was immunoprecipitated in different states of activation, using three different C. elegans genetic backgrounds: wild-type (DAF-16 partially active), daf-2(e1370ts) at restrictive temperature (insulin/IGF receptor mutant; DAF-16 fully active) or daf-18(mg198lf) (PTEN mutant, causing constitutively high PIP 3 signalling that, in turn, constitutively activates the AKT kinases that phosphorylate and inactivate DAF-16/FOXO; DAF-16 inactive). Proteins that specifically co-purified with DAF-16/FOXO were identified by liquid chromatography followed by tandem mass spectrometry (see also Fig. 1c ). In addition to previously known DAF-16/FOXO-binding partners (that is, the 14-3-3 proteins FTT-2 and PAR-5 (ref. 5)), we identified 131 new binding partners of DAF-16/FOXO, most of which were enriched in purifications of active DAF-16/FOXO ( Supplementary Table S1 ).
To identify potential DAF-16/FOXO cofactors amongst these binding partners, we silenced their expression by RNAi and examined a range of ageing and gene expression phenotypes expected from altered DAF-16/FOXO activity: to identify cofactors required for DAF-16/FOXO activity, we tested each gene inactivation for impaired DAF-16/FOXO-induced lifespan extension or an inability to upregulate the DAF-16/FOXO-activated gene sod-3 in daf-2 mutant animals ( Table 1 and Supplementary Tables S2 and S3 ). To identify interacting proteins that antagonize DAF-16/FOXO activity, we tested each gene inactivation for an extension of lifespan or inappropriate induction of sod-3 in otherwise wild-type animals ( Supplementary Tables S4-S6 ). Out of 72 DAF-16/FOXO-binding partners tested, inactivation of the genes encoding 32 of them caused significant phenotypes in at least one of the assays. Thus, they were considered candidate cofactors of DAF-16/FOXO (Table 1 and Supplementary Table S6 ). Comparison of the frequency of phenotypes in Supplementary Table S2 with a similar genome-wide survey 6 indicated that our list of binding partners was more than 20-fold enriched for proteins involved in DAF-16/FOXO function, underscoring the utility of this co-purification approach. Many of the 32 candidate cofactors act in the regulation of chromatin and transcription (for example, SWSN-1, SWSN-3, BAF-1, ELB-1, DCP-66, DPY-30, ZFP-1 and MRG-1) or protein folding and homeostasis (for example, RPN-9, RPN-12, CCT-8, PFD-6 and PFD-2; Table 1 ; Supplementary Table S6 ), both of which are Supplementary Tables S2-S6 . MS/MS, tandem mass spectrometry. *For rpn-9, baf-1 and cct-8 several RNAi clones were tested and the results were averaged for this table. † For a description of the GFP expression scoring scale, see Supplementary Table S3 . ‡ The intensity of the red colour denotes the intensity of the phenotype.
important for stress response and lifespan regulation 7, 8 . Some of the candidate cofactors even emerged from previous ageing-related studies; for example, BAF-1 controls age-dependent muscle integrity 9 and CCT-8 is a component of the lifespan-regulatory cytosolic chaperonin T complex 10 .
SWI/SNF binds to and co-localizes with DAF-16/FOXO
Although follow-up of several of these candidate cofactors may yield compelling insight into DAF-16/FOXO mechanism and function, we focused on a candidate with particularly strong phenotypes in both regulation of lifespan and expression of sod-3: SWSN-1 (orthologue of human BAF155 and BAF170), a core subunit of the chromatin remodeller SWI/SNF. Two other SWI/SNF subunits, SWSN-3 (orthologue of human BAF57) and SWSN-8 (orthologue of human BAF250 or OSA), were amongst our 32 candidate cofactors or at least emerged from the proteomic analysis (Table 1 and Supplementary Table S1 ). SWI/SNF is an essential multi-subunit complex with a relative molecular mass of 1,000,000-2,000,000 that repositions, exchanges or displaces nucleosomes in an ATP-dependent manner 11, 12 (Supplementary Fig. S1a,b) . The BRG1 or BRM orthologue SWSN-4 provides the complex's catalytic activity and comprises, together with SWSN-1 and SNFC-5 (orthologue of INI1), its core subunits 13 . Other accessory subunits direct the specificity of the complex. In particular, two subclasses of SWI/SNF, BAF and PBAF, which differ by the presence of accessory signature subunits (in particular SWSN-8 and PBRM-1 (orthologue of Polybromo); Supplementary Fig. S1a,b ), show distinct functions 14, 15 . Although chromatin remodelling is a ubiquitous process, the roles of SWI/SNF are surprisingly confined. For example, in yeast only 6% of all gene expression events depend on SWI/SNF (ref. 16 ), suggesting that particular mechanisms direct SWI/SNF to specific sites.
In C. elegans, studies on SWI/SNF have remained few-mostly focused on its role in asymmetric T-cell division and gonad morphogenesis 15, 17 . To explore the relationship between DAF-16/FOXO and SWI/SNF, we first confirmed the interaction between DAF-16/FOXO and SWI/SNF subunits (including its catalytic core SWSN-4) and excluded the possibility of a DNA-mediated interaction by co-immunoprecipitation in the presence of Benzonase, a nuclease that degrades DNA and RNA ( Fig. 1d,e ). Next we determined in which tissues and subcellular compartments DAF-16/FOXO and SWI/SNF are co-expressed and hence their interaction may occur. Both were expressed globally, including the tissues important for DAF-16/FOXO function (in particular intestine and neurons 17, 18 ; Supplementary Fig. S1c ). Whereas inactive DAF-16/FOXO (for example, in daf-18(mg198lf)) is sequestered in the cytoplasm and translocates to the nucleus only on its activation (for example, in daf-2(e1370ts)), SWI/SNF subunits resided constitutively in the nucleus 15, 17, 19 ( Supplementary Fig. S1c ; data not shown). Consistent with this observation, mass spectrometric comparison of the DAF-16/FOXO purifications from wild-type, daf-2(e1370ts) and daf-18(mg198lf) animals revealed a positive correlation between the activation of DAF-16/FOXO and its binding to SWI/SNF (comparison based on spectral counts, Supplementary Table S1 ). Thus, it seems that DAF-16/FOXO and SWI/SNF encounter each other in most cell types, with their interaction preferentially occurring following DAF-16/FOXO activation and translocation into the nucleus, in particular under low insulin-like signalling conditions.
SWI/SNF is required for DAF-16/FOXO-mediated transcriptional regulation
Next we evaluated the importance of SWI/SNF for DAF-16/FOXO activity. As DAF-16/FOXO exerts its function by transcriptional regulation of target genes, we investigated whether SWI/SNF is required for this regulation to occur. We used transcriptional reporters of two DAF-16/FOXO-regulated genes, sod-3 and ins-7, to examine DAF-16/FOXO-dependent transcriptional activation and repression, respectively 6, 20 . Expression of the Psod-3::GFP reporter is induced under conditions of low insulin-like signalling, for example, in daf-2 mutants 18 . Further inactivation by RNAi of DAF-16/FOXO or of the SWI/SNF core subunits SWSN-4 and SWSN-1 and the BAF-subclass signature subunit SWSN-8 suppressed this induction of Psod-3::GFP ( Fig. 2a,b ). Likewise, repression of Pins-7::ins-7::GFP was suppressed by RNAi against SWI/SNF subunits, in particular SWSN-4 and SWSN-1 and to a lesser extent SWSN-8, SWSN-3 and SNFC-5 ( Fig. 2c,d ). It is important to note that in contrast to the BAF-subclass signature subunit SWSN-8, RNAi against the PBAF-subclass signature subunits PBRM-1, TAG-298 (orthologue of BRD7) or SWSN-7 (orthologue of BAF200) (by validated RNAi conditions ( Supplementary Fig. S2 )) yielded no significant phenotypes in these assays, suggesting that specifically a BAF-like subclass of the SWI/SNF complex mediates DAF-16/FOXO functions.
We then examined whether SWI/SNF is required for the regulation of endogenous DAF-16/FOXO target genes genome-wide. By high-throughput sequencing of messenger RNA (mRNA-seq), we compared gene expression levels between wild-type, daf-2(e1370ts), daf-2(e1370ts); daf-16(0), and daf-2(e1370ts); swsn-1(os22ts) young adult animals at restrictive temperature. First we investigated whether daf-16(0) or swsn-1(os22ts) could suppress the differential gene expression caused by decreased insulin-like signalling in daf-2(e1370ts), which is thought to be entirely mediated by DAF-16/FOXO (ref. 3). As indicated by an extensive reversal of the differential gene expression to wild-type levels (78% of genes activated and 71% of genes repressed in the daf-2(e1370ts) mutant), daf-16(0) largely suppressed the gene expression changes induced by daf-2(e1370ts) (Fig. 3a,b ). Likewise, swsn-1(os22ts) significantly reversed this differential gene expression, although to a lesser extent (42% of genes activated and 32% of genes repressed in the daf-2(e1370ts) mutant were reverted; Fig. 3a,b ). This could be due to swsn-1(os22ts) being a non-null and therefore weaker allele than daf-16(0), SWSN-1 being less important, or it acting on only a subset of DAF-16/FOXO target genes. Next we determined the overlap between DAF-16/FOXO-and SWI/SNF-regulated genes. Importantly, although DAF-16/FOXO and SWI/SNF each regulate only a small fraction of the genome (5.9% and 7.5%, respectively), their dependent gene sets showed substantial and significant overlap: of the 656 genes activated and 356 genes repressed by DAF-16/FOXO in daf-2(e1370ts) animals, 32% (211) of the activated and 15% (53) of the repressed genes were co-regulated by SWI/SNF ( Fig. 3c ), suggesting that a large fraction of DAF-16/FOXO-mediated gene regulatory events require SWI/SNF. Gene Ontology term analysis of the co-dependent genes showed significant enrichment for genes involved in ageing, oxidative stress response and organismal defence ( Supplementary Table S7 ). Focusing on DAF-16/FOXO target genes, specifically for genes activated by DAF-16/FOXO we observed a strong positive correlation between the extent of DAF-16/FOXO-mediated activation and the requirement of SWI/SNF for this activation to occur (as indicated by a declining trend line in Fig. 3d , right panel). No such substantial correlation was found for genes non-regulated or repressed by DAF-16/FOXO (Fig. 3d , left and middle panels). Thus, SWI/SNF is required for the regulation of a large subset of DAF-16/FOXO target genes-predominantly those activated by DAF-16/FOXO.
DAF-16/FOXO and SWI/SNF co-localize on chromatin
We then sought the mechanism by which SWI/SNF impacts DAF-16/FOXO-mediated gene regulation. Given that SWI/SNF and activated DAF-16/FOXO are both known to associate with DNA (refs 2,11,12), we determined the genome-wide positioning of DAF-16/FOXO, the SWI/SNF catalytic subunit SWSN-4 and the SWI/SNF core regulatory subunit SWSN-1 in daf-2(e1370ts) animals at restrictive temperature using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq). Using strains expressing either DAF-16::GFP, SWSN-4::GFP or SWSN-1::GFP, we identified 1,952 binding sites for DAF-16/FOXO, 3,804 binding sites for SWSN-4 and 5,727 binding sites for SWSN-1. Despite our use of multi-copy transgenes that may be expressed at nonphysiological levels, we observed a reassuring enrichment for the canonical DAF-16/FOXO-associated motif TRTTTAC (ref.
3) at DAF-16/FOXO-binding sites. SWSN-4-and SWSN-1-binding sites were likewise enriched for several motifs, although motifs of less defined roles ( Supplementary Table S8 ). Interestingly, not only SWI/SNF-but also DAF-16/FOXO-binding sites shared enrichment for a motif known to associate with Trithorax-like, a protein of Drosophila melanogaster that is functionally related to SWI/SNF (ref. 21 and Supplementary Table S8 ). DAF-16/FOXO-binding sites in daf-2(e1370ts) correlated well with DAF-16/FOXO-binding sites previously identified in wild-type animals 4 ( Supplementary Fig. S3a ). Furthermore, DAF-16/FOXO as well as SWI/SNF-binding sites were mostly located within promoter regions, consistent with these proteins functioning in transcriptional regulation ( Fig. 4a ). Genes immediately downstream of DAF-16/FOXO-binding sites were strongly enriched for DAF-16/FOXO-activated genes, whereas they were depleted for DAF-16/FOXO-repressed genes ( Fig. 4b ). Of the directly regulated genes, 87% experienced activation and only 13% repression by DAF-16/FOXO, suggesting that DAF-16/FOXO is predominantly a transcriptional activator.
Given that DAF-16/FOXO and SWI/SNF form a complex (Fig. 1d ,e and Supplementary Table S1 ), we investigated whether they would co-localize also on chromatin. Indeed, SWSN-4 and SWSN-1 were strongly enriched right at the summits of DAF-16/FOXO-binding sites ( Fig. 4c,e ), supporting the model of DAF-16/FOXO-SWI/SNF interaction. Furthermore, the fact that this co-localization occurred not only at some but most DAF-16/FOXO-binding sites ( Fig. 4d,e ) further supports the intimate connection between DAF-16/FOXO and this cofactor.
DAF-16/FOXO recruits SWI/SNF to directly activated target genes
There is substantial precedence for transcription factors to employ chromatin remodellers as cofactors 12 . In the case of SWI/SNF, some transcription factors recruit it to target promoters to induce local nucleosome repositioning that alters the accessibility of cis-regulatory promoter elements to regulate transcription 22 . To determine whether DAF-16/FOXO employs SWI/SNF in a similar manner, we investigated whether their binding to DAF-16/FOXO target promoters depends on each other. Inactivation of SWI/SNF by use of swsn-1(os22ts) at restrictive temperature had no effect on DAF-16/FOXO expression, nuclear localization nor its binding to target promoters ( Fig. 5a and Supplementary Fig. S3b ,c). Next we examined the SWI/SNF catalytic core subunit, SWSN-4. Again, loss of DAF-16/FOXO did not alter SWSN-4 expression levels ( Supplementary Fig. S3b ), or its nuclear localization ( Supplementary Fig. S3c ), nor did we observe significant changes in the abundance of SWSN-4 at promoters that were either non-regulated or repressed by DAF-16/FOXO (Fig. 5b ). However, specifically at a large fraction of promoters that were directly bound and activated by DAF-16/FOXO (for example, promoters of sod-3, ctl-3 or hil-1) we observed a substantial loss of SWSN-4 binding in the absence of DAF-16/FOXO ( Fig. 5b,d ; Supplementary Fig. S4a ). As a further control, we investigated promoters that were activated by DAF- 16 Supplementary Fig. S4b ). We conclude that DAF-16/FOXO employs SWI/SNF as a cofactor in the manner previously described for other transcription factors, and hence we infer the following model for how DAF-16/FOXO may activate its target genes: DAF-16/FOXO binds promoters in a manner that is independent of SWI/SNF, presumably by directly accessing its target sequences, and at promoters that DAF-16/FOXO directly activates, it aids the recruitment of SWI/SNF, thereby inducing local chromatin remodelling. This remodelling enhances accessibility of activatory cis-regulatory promoter elements for binding by downstream Most Least Most Least Most Expression in wild-type (log 10 (FPKM)) Expression in wild-type (log 10 (FPKM)) components (for example, the transcription machinery), thereby resulting in transcriptional activation ( Supplementary Fig. S5 ).
SWI/SNF is required for DAF-16/FOXO-mediated dauer formation
Given our collective evidence that DAF-16/FOXO employs SWI/SNF as a gene-activation-specific cofactor, we then wondered about the importance of this cofactor for the various DAF-16/FOXO-mediated functions in the animal. In C. elegans, DAF-16/FOXO is required for entry into the dauer state, a developmental arrest or diapause state that allows for survival in many adverse conditions 23 . We induced this state by inactivating insulin-like signalling and tested whether RNAi against SWI/SNF subunits was able to suppress it. Consistent with SWI/SNF being an important cofactor to DAF-16/FOXO, not only loss Read count change at summit (log 2 (daf-16(0)/WT)) Dauer larvae (%)
RNAi: Indicated strains were grown to the L4 stage, when e1370 ts and os22 ts alleles were inactivated by a shift to restrictive temperature. Twenty-four hours later, animals were exposed to 6 mM tert-butylhydroperoxide (tBuOOH) and their survival was monitored. All survival data of panels (b-f) were obtained from a minimum of 100 animals per condition, mean survival times and s.e.m. were obtained by Kaplan-Meier analysis, and significant differences between conditions were determined by log-rank test (for exact numbers of animals and statistical data, see Supplementary Table S9 ).
of daf-16 but also of several SWI/SNF subunits prevented the formation of SDS-resistant dauer larvae (Fig. 6a ). On closer investigation, we found that in the absence of SWI/SNF, animals attempted dauer entry, but full execution of the dauer program failed, leading instead to a DAF-16/FOXO-dependent developmental arrest around the L3 stage ( Supplementary Fig. S6a ). These arrested animals lacked the typical longevity of dauer larvae and frequently were void of dauer-specific anatomical features such as the hypodermal alae or the pharyngeal plug ( Supplementary Fig. S6b-d) . Consistent with our gene expression data (Fig. 2b,d) , defective dauer formation was specifically observed on loss of either the core SWI/SNF subunits SWSN-4 and SWSN-1 or the BAF signature subunit SWSN-8, whereas loss of PBAF signature subunits PBRM-1, TAG-298 or SWSN-7 did not disrupt dauer formation. This once again implies a specific role for a BAF-like subclass of SWI/SNF in mediating DAF-16/FOXO functions. Given this loss-of-function phenotype for SWI/SNF, we also investigated whether overexpression of the SWI/SNF subunits SWSN-4 or SWSN-1 could promote dauer formation. Although gain-offunction phenotypes from such an approach may be difficult to obtain or interpret owing to the multi-subunit nature of the SWI/SNF complex and its requirement to be targeted to the appropriate sites, we observed a daf-16 -dependent moderate enhancement of dauer formation in daf-2(e1370ts) animals at 22 • C ( Supplementary Fig. S6e ).
SWI/SNF is required for DAF-16/FOXO-mediated longevity and stress resistance
Beyond its role in dauer formation, DAF-16/FOXO is a potent mediator of lifespan extension, in particular during decreased insulin-like signalling. Inactivation of the SWI/SNF core subunits SWSN-4 or SWSN-1 by RNAi fully suppressed this lifespan extension (Fig. 6b,d) . Partial suppression was seen on RNAi against the non-core subunit SWSN-3 ( Supplementary Fig. S7a ). Even postdevelopmental RNAi against SWI/SNF subunits was sufficient to partially suppress DAF-16/FOXO-induced lifespan extension ( Fig. 6e and Supplementary Fig. S7b ). All lifespan phenotypes induced by SWI/SNF RNAi were diminished in daf-16(0) mutant worms, consistent with SWI/SNF functioning as a cofactor to and thus in the same pathway as DAF-16/FOXO (Fig. 6c,e and Supplementary  Fig. S7b ). We further confirmed these phenotypes by mutant analysis. Consistent with the RNAi results, the hypomorphic alleles swsn-4(os13ts) and swsn-1(os22ts) each impaired DAF-16/FOXO-mediated lifespan extension ( Supplementary Fig. S7c,d) . Unlike other SWI/SNF alleles or RNAi conditions tested, the particularly strong allele swsn-1(os22ts) shortened the lifespan of daf-16(0) animals, showing that SWI/SNF has some lifespan effects that are independent of DAF-16/FOXO. However, consistent with a requirement of SWI/SNF for DAF-16/FOXO function and thus the two acting in the same pathway, daf-16(0) failed to shorten the lifespan of swsn-1(os22ts) animals ( Supplementary Fig. S7d) .
The lifespan-extending capabilities of DAF-16/FOXO are highly correlated with its ability to induce stress response pathways 3, 24 . We investigated whether SWI/SNF is required for the DAF-16/FOXO-mediated stress resistance of insulin-like signalling mutants. Inactivation of SWI/SNF by swsn-1(os22ts) or swsn-3 (RNAi) specifically blocked the enhanced resistance of daf-2 mutants to oxidative stress (tBuOOH; Fig. 6f and Supplementary Fig.  S7e ). In addition, swsn-1(os22ts) was able to block enhanced resistance of daf-2 mutants to heat stress (32 • C; Supplementary  Fig. S7f ). Inactivation of SWI/SNF showed a lesser effect in daf-16 mutant backgrounds ( Fig. 6f and Supplementary Fig. S7e,f) , again suggesting that SWI/SNF functions in the same pathway as DAF-16/FOXO. Thus, consistent with SWI/SNF being an important cofactor to DAF-16/FOXO, it is not only required for DAF-16/FOXO-mediated gene regulation, but it actually is required for a broad range of DAF-16/FOXO-mediated functions in the animal, in particular dauer formation, stress resistance and the promotion of longevity.
DISCUSSION
Despite our extensive knowledge of pathways leading to DAF-16/FOXO activation, it long remained elusive by which means and the help of which cofactors activated DAF-16/FOXO regulates transcription and thus confers its suite of beneficial effects on the organism. Our study provided the first systematic identification of DAF-16/FOXO cofactors, which in itself provides a significant resource for future studies, and by focusing on its most prominent candidate, the chromatin remodeller SWI/SNF, we were able to illuminate the transcription-regulatory events downstream of DAF-16/FOXO activation. We showed that DAF-16/FOXO is predominantly a transcriptional activator and provided mechanistic insight into how this activation may be achieved-namely by DAF-16/FOXO recruiting a BAF-like subclass of SWI/SNF to target promoters. Extensive exploration of SWI/SNF function in other systems suggests that this recruitment induces local chromatin remodelling to enable binding of downstream transcriptional components and thereby activates transcription 22 . These findings also agree with previous implications of DAF-16/FOXO as a pioneer transcription factor 25, 26 , suggesting that specifically on pro-longevity stimuli DAF-16/FOXO is activated and autonomously binds to a wide range of target promoters where it nucleates their transcriptional activation by alteration of chromatin states.
Chromatin states and their alteration were previously shown to have profound stress-responsive and lifespan-regulatory effects, but those described alterations were mostly limited to epigenetic changes (in particular histone methylation 27, 28 or acetylation 29 ) and their mechanistic link to known stress-responsive and lifespan-regulatory pathways often remained unclear. We have now established DAF-16/FOXO-controlled stress-responsive and lifespan-regulatory roles for a type of chromatin alteration fundamentally distinct from epigenetic changes, namely ATP-dependent chromatin remodelling conferred by SWI/SNF. This opens a new dimension to how an alteration of chromatin states can regulate stress response and longevity. Furthermore, any potential cross-talk between this ATP-dependent chromatin remodelling and lifespan-regulatory epigenetic marks will be important to investigate in the future. For example, enrichment of SWI/SNF at DAF-16/FOXO-binding sites is substantially but not entirely dependent on DAF-16/FOXO (Fig. 5b-d and Supplementary  Fig. S4 ) and thus may be supported by other factors or epigenetic marks, with histone acetylation being a strong candidate 30 .
Finally, it should be noted that FOXO and SWI/SNF are both evolutionarily conserved and that FOXO also has lifespan regulatory roles in humans 31, 32 . Hence, the here described roles of SWI/SNF may be conserved, and their further exploration may eventually benefit our understanding of ageing and age-related diseases in humans.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb2720 METHODS C. elegans were grown on E. coli OP50 using standard techniques 33 .
Strains and alleles. daf-16(mgDf47) was referred to as daf-16(0) throughout the manuscript. Strains containing Is[daf-16P::daf-16::GFP; rol-6(su1006)] were all derived from strain TJ356 (ref. 19) . For a detailed list of the used strains, see Supplementary Table S10 .
RNAi by feeding. C. elegans were grown on E. coli HT115 containing dsRNAexpressing plasmids from published collections [34] [35] [36] . For swsn-4, an analogous RNAi clone was generated by use of the following primers: 5 -cgcgaagctcgtgttacc-3 / 5 -acttcgttgaccttccagtatg-3 . HT115 containing empty plasmid served as a control throughout the manuscript.
Preparation of C. elegans lysates for size-exclusion chromatography and immunoprecipitations. C. elegans were grown asynchronously at 15 • C, then shifted for 20 h to 25 • C and collected. Animals were washed into lysis buffer (50 mM HEPES at pH 7.4, 1 mM EGTA, 1 mM MgCl 2 , 150 mM KCl, 10% (v/v) glycerol, Complete (Roche), 1 mM phenylmethyl sulphonyl fluoride and phosphatase inhibitors (Calbiochem)) and lysed by either bead beating or grinding under liquid nitrogen. NP-40 was added to 0.05% (v/v), and the resulting lysate was cleared at 20,000g .
Size-exclusion chromatography. Worm lysates were run on a Superose 6 10/300 column (GE Healthcare) in lysis buffer containing 0.05% (v/v) NP-40.
DAF-16/FOXO purification (large scale).
C. elegans lysate (20 ml) at a protein concentration of 20 mg ml −1 was prepared as mentioned above. GFP-tagged DAF-16/FOXO was immunoprecipitated using anti-GFP antibody (3E6, Invitrogen) coupled to Protein A resin (Biorad). Immunoprecipitated proteins were eluted using 100 mM glycine at pH 2.6. As negative controls for background subtraction in Supplementary Table S1 , the purification and later mass spectrometry analyses were conducted using wild-type C. elegans and C. elegans expressing unconjugated GFP from a ubiquitously expressing promoter (strain GR1912).
Mass spectrometry. Samples were digested overnight at pH 8.3 using sequencinggrade trypsin and the resulting peptides separated by micro-capillary reverse-phase chromatography and identified by online tandem mass spectrometry using an LTQ Orbitrap XL hybrid linear ion trap-orbitrap high-resolution mass spectrometer (Thermo). Tandem mass spectra produced by collision induced dissociation (CID) in the ion trap were searched against the Wormpep database (version 221) using ProLuCID (ref. 37 ) and DTASelect (ref. 38 ). False discovery rates (FDRs) were determined by searching the mass spectra against the reversed sequences of the Wormpep database. For the data in Supplementary Table S1 , proteins had to be identified by a minimum total of two independent peptides across experiments, resulting in an FDR below 1%. Samples were compared using Contrast 38 . Any proteins that were identified also in the control purifications were probably contaminants and thus eliminated from Supplementary Table S1 , unless they were identified by at least fivefold higher spectral counts in the combined DAF-16 purifications.
Co-immunoprecipitation. Worm lysates were prepared as mentioned above.
FLAG-tagged DAF-16/FOXO was immunoprecipitated using M2 antibody resin (Sigma) and eventually eluted using 250 µg ml −1 3xFLAG peptide. GFP-tagged SWSN-4 was immunoprecipitated using GFP-Trap resin (Chromotek).
Reporter assays. C. elegans strains CF1580 or GR1911 were seeded as synchronized L1 onto plates with RNAi bacteria, grown at 15 • C until the L4 stage, and then shifted to 25 • C. Production of progeny was prevented by post-developmental exposure to 5-fluoro-2'-deoxyuridine (FUDR; ref. 39) . GFP expression was analysed on day 4 of adulthood, using Zeiss Discovery V12 and Zeiss Axio Imager fluorescence microscopes.
mRNA isolation, reverse transcription and qPCR. Animals were seeded by egg-lay onto plates with OP50 bacteria, grown at 15 • C until the L4 stage, and then shifted for 20 h to 25 • C. Animals were collected and total RNA extracted using Trizol. mRNA quantification by reverse transcription and qPCR was performed as previously described 40 . Samples were normalized to Y45F10D.4 transcript levels 41 . Experiments were conducted in biological duplicate. Primers used were previously published 41, 42 or as follows: ins-7 5 -GCATGCGAATCGAATACTGA-3 /5 -GAAGTCGTCGGTGCATTCTT-3 , hsp-12.6 5 -GGAGATGGAGTTGTCAATGTCCT-3 / 5 -TCCTTCTTTACATTGT-GCTCCA-3 .
ChIP-qPCR. Animals were grown asynchronously at 15 • C and then shifted for 20 h to 25 • C. ChIP was performed in biological duplicate as previously described 40 . Primers used for qPCR were: hil-1P 5 -ACAATTCGTTCGTCGGTCTC-3 / 5 -AGGACGGGCCTCTTCTATTC-3 , ctl-3P 5 -TATAAAAGAGGCGGCCAGAC-3 / 5 -CCTTCTCAGCGAGCAGTTCT-3 , control ( Supplementary Fig. S4b , left panel) 5 -CTCTTCATTTTGTTCCTGTGTTTTCC-3 / 5 -GAAGGCGGCGGTAATTGT-TG-3 , control ( Supplementary Fig. S4b , middle and right panel) 5 -AC-TGGGAGTGGTTCAAGTGG-3 /5 -TACCTCCAGCACCACCTTCT-3 . Primers for sod-3P were published previously 42 . Processing of mRNA-seq reads and differential expression analysis. Reads were aligned to the C. elegans genome with the TopHat (v2.0.4) software package 44 using known gene model annotations (WS220). Transcript abundance (FPKM, fragments per kilobase of transcript per million fragments) and differential expression were calculated using Cuffdiff (v2.0.2) included in the Cufflinks software package 45 using the following parameters: -m 160 -s 40 -u -upper-quartile-norm -compatible-hits-norm -library-type fr-unstranded. All conditions/samples were analysed in biological duplicate. Statistically significant differentially expressed genes (DEGs) were identified using a 5% FDR. Differential gene expression values were calculated as the ratio of FPKM values. To test for significant overlap between gene lists (Fig. 3c ) the hypergeometric test was used (phyper R function).
To determine the function of SWSN-1 at DAF-16-regulated genes (Fig. 3d ), all protein-coding genes were classified as DAF-16 activated, repressed or unregulated (Cuffdiff, 5% FDR) and differential gene expression values were calculated (relative to daf-2(e1370ts) control). Unexpressed genes having a FPKM of 0 in any of the samples were removed from analysis. Genes were ordered from least to most mis-expressed in daf-2(e1370ts); daf-16(0) for each class of genes and the corresponding differential expression level in daf-2(e1370ts); swsn-1(os22ts) was plotted. Finally, a smoothed line representation of the data was plotted using cubic splines (smooth.spline R function, spar = 0.6).
ChIP-seq read processing, peak calling and metagene analysis. Reads were aligned to the C. elegans genome (WS220) using Bowtie (v0.12.8) with the following parameters: -m 1 -best -strata 46 . Uniquely mapping reads containing no more than one mismatch were used for peak calling and read density calculations. Enriched peaks were identified using MACS (v1.4.0) with the following parameters: -mfold = 5,30 -bw = 175 -keep-dup = auto 47 . Statistically significant peaks (P < 1×10 −5 ) were filtered using a 1% FDR. Genomic regions that are commonly identified in ChIP-seq experiments, so-called hotspots, represent potential artefacts and were removed from the peak data set as previously described 48 . Data were generated from one of two biological replicates whose reproducibility had been confirmed by ChIP-qPCR at various loci ( Supplementary Fig. S4b ).
To calculate genome-wide read densities, reads were first extended to mean fragment size (175 base pairs (bp)) in the 3 direction of the read to more precisely reflect the true binding position. Next, the number of reads within 25-bp non-overlapping bins was determined across the genome and each read count was normalized by the library size. This procedure was performed for both immunoprecipitation and input ChIP samples. The input read count was then subtracted from the immunoprecipitation count for every bin. To compare DAF-16::GFP, SWSN-4::GFP or SWSN-1::GFP binding at DAF-16 peaks (Figs 4c-e, 5a-c and Supplementary Fig. S3a ), the normalized genome-wide read counts for the two samples were first quantile-normalized using the preprocessCore R package 49 . The bin overlapping each DAF-16 peak summit (MACS) was identified and the mean normalized read count was calculated for each sample. This process was repeated for 40 bins upstream and 40 bins downstream of the peak summit (±1,000 bp). Data smoothing was performed before plotting the data with cubic splines (smooth.spline R function, spar = 0.5). For P-value calculations in Fig. 5a,b , indicating whether DAF-16 or SWSN-4 binding had significantly changed between the compared samples, we first determined for each sample the sum of all reads in each of the 81 bins surrounding the DAF-16 peak summits (see above). The resulting 81 data points were then compared between samples by a t -test 50 .
Overlap between sets of binding sites was determined using intersectBED of the BEDTools Utility suite 51 (Fig. 4d) .
Associating ChIP-seq peaks with proximal genes. First, the distance between each peak summit (MACS) and nearby transcriptional start sites (TSS) of proteincoding genes was calculated. A peak summit positioned within 2.5 kb upstream or 300 bp downstream of a TSS was assigned to that gene. If multiple genes could be assigned to a single peak, the closest TSS was selected. If no TSS was found in this window, the peak was left unassigned. Using this approach, genes could be assigned to ∼70% of the ChIP-seq peaks (bound genes). The distribution of peak to TSS distances is plotted in Fig. 4a , which also includes long-range distances that fall outside the −2.5 kb to +300 bp window. Finally, enrichment of differential gene expression for bound genes (Fig. 4b ) was calculated as (number of bound DEGs/ number of bound expressed genes) / (number of DEGs/ number of expressed genes), where expressed genes are defined as genes where FPKM > 0 in the daf-2(e1370ts) and daf-2(e1370ts); daf-16(0) samples.
Identification of DNA motifs enriched at DAF-16/FOXO-and SWI/SNFbinding sites.
Binding sites obtained from ChIP-seq analysis were searched for enriched DNA motifs using peak motifs at http://rsat.ulb.ac.be. Searches were conducted using default parameters and an oligomer length of 7. Significance scores were determined as previously described 52 .
Dauer assays. C. elegans strains CB1370, GR1309, GR1900 or GR1908 were seeded by egg-lay onto RNAi bacteria and grown at 25 • C. Animals were evaluated after 5 days, either by scoring their dauer morphology or their survival of a 30 min treatment with 1% (w/v) SDS (ref. 53) .
Lifespan assays of gene inactivations by RNAi. C. elegans strains GR1373, GR1899, GR1901 or AU119 were seeded as synchronized L1 onto RNAi bacteria, grown at 15 • C until the L4 stage, and then shifted to 20 • C. Production of progeny was prevented by post-developmental exposure to FUDR (ref. 39 ). Survival of animals was assayed every 2 days, as described previously 39 . Gene inactivation by post-developmental RNAi and the large-scale screening of Supplementary Tables S2  and S4 were conducted as previously described 6, 10 .
Lifespan assays of mutants. Animals were seeded by egg-lay onto OP50 bacteria, grown at 15 • C until the L4 stage, and then shifted to 25 • C. Production of progeny was prevented by post-developmental exposure to FUDR (ref. 39 ). Survival of animals was assayed every 2 days, as described previously 39 .
Stress assays. For oxidative stress under RNAi, animals were seeded by egg-lay onto plates with RNAi bacteria, grown at 15 • C until the L4 stage, and then shifted to 20 • C. From day 1 of adulthood, animals were exposed to 6 mM tert-butylhydroperoxide (tBuOOH) and their survival was scored, as previously described 54 . For stress assays of mutant animals, animals were seeded by egg-lay onto plates with OP50 bacteria, grown at 15 • C until the L4 stage, and then shifted to 25 • C. From day 1 of adulthood, animals were exposed to 6 mM tBuOOH (oxidative stress) or shifted to 32 • C (heat stress) and their survival was scored, as previously described 54 .
Microscopy. Live animals were analysed at ×65 magnification using a Zeiss Discovery V12 microscope. For imaging, worms were paralysed with 2,3butanedione monoxime, mounted on agarose pads, and imaged on a Zeiss Axio Imager at magnifications of ×100, ×400 or ×630. Riedel et al., Figure S1 . 
Statistical analysis. Lifespan and stress resistance assays were evaluated by

